Skip to main content
COVID-19 Positive?

COVID-19 Positive?

Don’t lose valuable treatment time. Prescription antivirals like PAXLOVID™ and Molnupiravir can help reduce symptoms and keep you out of the hospital. Find out if you’re eligible for treatment with an online consultation from Dr. B. Medical consultations are only $15 or you can apply for a no-cost* option based on financial need.


Important safety information about PAXLOVID™ and Molnupiravir.
Prescription treatment requires a virtual consultation with a medical provider to determine if a prescription is appropriate.


Start A Consultation With Dr. B >>


How It Works

  1   Test using INDICAID COVID-19 OTC Rapid Antigen At-Home Test

  2   Complete a virtual health assessment with Dr. B

  3   Pay a $15 medical consultation fee

  4   Choose your pharmacy (online or your local spot)

  5   A medical provider will review your treatment

  6   If a prescription is appropriate, it will be sent to your pharmacy


Get Started


PHASE Scientific Americas & Dr. B

PHASE Scientific Americas & Dr. B

PHASE Scientific Americas, a health diagnostics innovator, and Dr. B have partnered to bring you an affordable Test-to-Treat option, helping reduce the time between diagnosis and treatment.

Using INDICAID Test-to-Treat powered by Dr. B allows patients to get virtual treatment for COVID-19—regardless of their ability to pay. If you test positive with an INDICAID COVID-19 Rapid Antigen At-Home Test, you can submit a photo of your test result in your medical consultation for possible treatment.




Easy to use
Non-invasive shallow nasal swab collection with 4 simple steps


Accurate results in 20 minutes
Clinically validated with overall sensitivity and specificity at 81.7% and 99.4% respectively, with an overall accuracy of 93.4%


Suitable for all individuals 2+ years old
Regardless of vaccination status, the rapid antigen test is suitable for all symptomatic and asymptomatic individuals


Detects SARS-CoV-2 (COVID-19) variants
Effective at detecting newly emerged variants, including delta and omicron



Dr. B


For more information about Dr. B's services, including customer service and past consultations, visit

© 2023 Dr.B, a Public Benefit Corporation        About Dr. B        Privacy Policy



PHASE Scientific Americas, as the test diagnostics provider, is solely providing the tests. PHASE Scientific Americas is not involved in providing any telehealth and treatment services. All telehealth and treatment services are provided by our partner, Dr. B.


Dr. B-affiliated medical practices are independently owned and operated by licensed physicians who provide services using the Dr. B telehealth platform. Get more information about the relationship between Dr. B and the medical practices.

* Financial hardship assistance available for those who qualify


PAXLOVID was approved for emergency use by the FDA December 2020 and was fully approved by the FDA May 2023. MOLNUPIRAVIR has been authorized for emergency use by the FDA under an EUA. These approvals allow PAXLOVID and MOLNUPIRAVIR treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) who are at high-risk for progression to severe COVID-19, including hospitalization or death. The emergency use of MOLNUPIRAVIR is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization revoked sooner.